BA
RDY icon

Bridgewater Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bridgewater Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Buy
37,404
+4,164
+13% +$58K 0.03% 258
2025
Q4 		$441K Sell
33,240
-1,004
-3% -$14.1K 0.03% 285
2025
Q3 		$461K Sell
34,244
-1,388
-4% -$20K 0.03% 263
2025
Q2 		$526K Buy
35,632
+3,659
+11% +$52.3K 0.04% 238
2025
Q1 		$446K Buy
31,973
+880
+3% +$12.1K 0.04% 246
2024
Q4 		$474K Buy
+31,093
New +$467K 0.05% 115

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bridgewater Advisors's RDY Position: Q1 2026 in Review

Bridgewater Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 13% in Q1 2026, buying an estimated $58K and bringing the position to 37,404 shares worth $486K. The position accounts for 0.03% of the portfolio, ranked #258.

Bridgewater Advisors first reported a position in RDY in Q4 2024 and has held it in 6 quarters since. The position peaked at $526K in Q2 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Bridgewater Advisors held 37,404 shares of Dr. Reddy's Laboratories worth $486K as of Q1 2026.
  • Bridgewater Advisors bought 4,164 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $58K.
  • Dr. Reddy's Laboratories made up 0.03% of Bridgewater Advisors's portfolio in Q1 2026, its #258 holding.
  • Bridgewater Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Bridgewater Advisors's Dr. Reddy's Laboratories position peaked at $526K in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.